Woodline Partners

Founded 2018

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 20
Average round size
info
The average size of a deal this fund participated in
$149M
Portfolio companies 18
Rounds per year 6.67
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 5
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Pharmaceutical

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Arbor Biotechnologies

Biopharma
Biotechnology
Life Science
$215M09 Nov 2021 Cambridge, Massachusetts, United States

Cedilla Therapeutics

Biotechnology
Health Care
Therapeutics
$25M25 Oct 2021 Cambridge, Massachusetts, United States

ShouTi

Biotechnology
Health Care
Medical
Pharmaceutical
Product Research
$100M20 Oct 2021 Shanghai, China

Jasper Therapeutics

Biotechnology
Health Care
Pharmaceutical
$100M27 Sep 2021 Latvia, Courland, Latvia

SmartNews

Apps
Journalism
Media and Entertainment
Mobile
News
$230M15 Sep 2021 Chiyoda, Japan

LEXEO Therapeutics

Biotechnology
Life Science
Therapeutics
$100M09 Sep 2021 New York, New York, United States

Tango Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$186M11 Aug 2021 Cambridge, Massachusetts, United States

Frontier Medicines

Artificial Intelligence
Biotechnology
Pharmaceutical
$88M19 Jul 2021 San Francisco, California, United States

Kriya Therapeutics

Biotechnology
Life Science
$100M14 Jul 2021 Palo Alto, California, United States
News
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform

– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.

News aggregator SmartNews raises $230 million, valuing its business at $2 billion

– SmartNews, a news aggregation website and app, raised $230m in Series F funding.
– The round was led by Princeville Capital and Woodline Partners, and joined by JIC Venture Growth Investments, Green Co-Invest Investment, and Yamauchi-No.10 Family Office in Japan.
– Existing investors participated in this round including ACA Investments and SMBC Venture Capital.
– The company plans to develop more features for its U.S. audience that will focus on consumer health and safety.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Woodline Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: